Sudden Death, Risk Stratification and Prevention in Hypertrophic Cardiomyopathy

Share:

Listens: 0

Minneapolis Heart Institute Foundation Cardiology Grand Rounds

Science


Dr. Barry J. Maron, Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of the implantable cardioverter defibrillator in HCM patients.